Orrstown Financial Services (ORRF) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Net income for Q4 2024 was $13.7 million ($0.71 per diluted share), rebounding from a net loss of $7.9 million in Q3 2024 and up from $7.6 million in Q4 2023; adjusted net income was $16.7 million ($0.87 per share) excluding non-recurring charges.
Achieved targeted 18% cost savings in operating run rate post-merger; core conversion completed in November 2024.
Board declared a $0.26 per share dividend, a 13% increase, payable February 2025.
Financial highlights
Net interest income was $50.6 million in Q4 2024, down from $51.7 million in Q3 2024; net interest margin decreased to 4.05% from 4.14%.
Noninterest income fell to $11.2 million from $12.4 million sequentially, mainly due to fee waivers and absence of prior tax credits.
Noninterest expenses dropped to $42.9 million from $60.3 million, reflecting lower merger and retirement costs.
Provision for credit losses was $1.8 million, down sharply from $14.1 million in Q3 2024.
Tangible book value per share rose to $21.19 from $21.12 sequentially.
Outlook and guidance
Management expects to focus on growth and shareholder value after successful integration and cost savings.
Some additional merger-related expenses anticipated in Q1 2025.
Latest events from Orrstown Financial Services
- Record earnings, strong loan growth, and higher dividend highlight robust 2025 results.ORRF
Q4 20253 Feb 2026 - Shelf registration allows up to $200M in securities for flexible corporate funding and growth.ORRF
Registration Filing29 Jan 2026 - Q1 2025 net income and EPS surged, with strong capital and lower merger costs.ORRF
Q1 202523 Dec 2025 - Major merger, robust financials, and key governance votes highlight this year's proxy.ORRF
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, improved efficiency, a dividend hike, and share repurchase authorization.ORRF
Q2 202516 Nov 2025 - Q3 2025 net income hit $21.9M, with record margins, strong growth, and robust capital.ORRF
Q3 20256 Nov 2025 - Q3 2024 loss from merger costs offset by strong adjusted earnings and loan growth.ORRF
Q3 202413 Jun 2025 - Q2 net income declined, but dividend rose 15% and Codorus merger integration is on track.ORRF
Q2 202413 Jun 2025